Profile icon Tick icon small Search icon Mobile nav icon Pin icon Linkedin icon Facebook icon Instagram icon Email icon Telephone icon Arrow down icon Logo Contact
01 July 2021

Aztec Group supports US$375 million close of Endeavour Medtech Growth II LP

We’ve supported leading venture capital and growth equity firm, Endeavour Vision with the fundraising activities and final close of its latest fund, Endeavour Medtech Growth II LP (“EMG II LP”).

EMG II LP closed with commitments of US$375 million, and will continue Endeavour Vision’s previous fund’s strategy of investing in high-potential European and US companies delivering transformative healthcare technologies, with the aim of improving the standard of care and bring efficiencies to healthcare systems. In particular, the fund will focus on growth stage companies that have overcome clinical and regulatory hurdles and are starting to generate commercial traction.

Aztec Group supported with the establishment of EMG II LP and will continue to provide ongoing administration and accounting services to the fund and its investment structures from our Guernsey office. Owner-managed, the Group specialises in alternative investments, administering more than €440 billion in assets, 450 funds and 4,500 entities for a range of clients, spanning the major asset classes including private equity, venture capital, private debt, real estate and infrastructure.

Nick Barton, Associate Director – Private Equity, said: “Congratulations to Endeavour Vision on such a successful final close of this latest fund, which is a clear reflection of the market’s confidence in its team and investment strategy. Medtech is a rapidly changing sector, particularly against the current backdrop of Covid-19 which has set the stage for accelerated healthcare innovation. It was a pleasure to work with the Endeavour Vision team and we look forward to continuing to build on our strong partnership.”

Endeavour Vision is one of the largest international investment teams focused on medtech and digital health. The firm was founded in 2000 and invests in growth-stage medtech and digital health companies in Europe and the US, with over US$500 million invested in 42 companies to date.

Stuart Manning, Partner & Director of Finance at Endeavour Vision added: “Our healthcare systems’ strategic importance and its current limitations has never been more apparent. These factors combined are accelerating the demand for pioneering solutions that can deliver sustainable healthcare. As such, EMG II LP’s timing could not be better. Aztec Group supported us through the set-up, AML and fundraising processes, working to our deadlines and delivering a seamless experience for us and our investors – even in the remote environment. We have every confidence that their support will be instrumental as we continue to invest in this dynamic sector.”

According to a recent survey conducted by Acuris and the Aztec Group of Europe’s private equity CFOs and COOs, the majority noted that they are planning to outsource more functions in order to reduce operating costs while managing rising regulatory risks. The survey results also showed that almost all respondents (98%) say investors are directly driving the need for new operational solutions.

The full report can be downloaded here.


Aztec Group eNews